Development of a multiplex lateral flow strip test for foot-and-mouth disease virus detection using monoclonal antibodies  by Yang, Ming et al.
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a  b  s  t  r  a  c  t
Foot-and-mouth  disease  (FMD)  is  one  of the  world’s  most  highly  contagious  animal  diseases  with  tremen-
dous  economic  consequences.  A rapid  and  speciﬁc  test  for FMD  diagnosis  at  the  site of  a  suspected
outbreak  is  crucial  for the  implementation  of  control  measures.  This  project  developed  a multiplex  lat-
eral ﬂow  immunochromatographic  strip  test  (multiplex-LFI)  for  the rapid  detection  and  serotyping  of
FMD viruses.
The monoclonal  antibodies  (mAbs)  against  serotypes  O,  A, and  Asia  1 were  used as  capture  mAbs.  The
mAbs  were conjugated  with  ﬂuorescein,  rhodamine  or biotin  for serotype  O,  A  and  Asia  1,  respectively.
The  detection  mAbs  which  consisted  of  a  serotype-independent  mAb  in combination  with  one  serotype
A-speciﬁc  mAb  and one  Asia  1-speciﬁc  mAb,  were  each  colloidal  gold-conjugated.  The  strips  used  in  this
study  contained  one  control  line  and  three  test  lines,  which  corresponded  to  one  of  the  three  serotypes,
O,  A or  Asia  1.
The  newly  developed  multiplex-LFI  strip  test  speciﬁcally  identiﬁed  serotype  O (n =  46),  A (n  =  45)  and
Asia  1  (n  = 17)  in  all tested  ﬁeld  isolates.  The  sensitivity  of  this  strip  test  was  comparable  to  the  dou-
ble  antibody  sandwich  ELISA  for serotypes  O and  A,  but  lower  than  the  ELISA for serotype  Asia 1. The
multiplex-LFI  strip  test  identiﬁed  all tissue  suspensions  from  animals  that  were  experimentally  inocu-
lated  with  serotypes  O,  A  or Asia 1. FMD  viruses  were  detected  in 38%  and  50%  of  the swab  samples  from
the  lesion  areas  of  experimentally  inoculated  sheep  for serotypes  O and  A, respectively.
The  capability  of  the  multiplex-LFI  strip  tests  to produce  rapid  results  with  high  speciﬁcity  for  FMD
viruses  of  multiple  serotypes  makes  this  test  a valuable  tool  to detect  FMD  viruses  at  outbreak  sites.
 201Crown  Copyright  ©
. Introduction
Foot-and-mouth disease (FMD) remains one of the world’s most
idespread epizootic and a highly contagious animal disease that
ffects a wide host range of cloven-hoofed farm animals, such
s cattle, buffaloes, pigs, sheep, and goats, and approximately 70
ildlife species (Coetzer et al., 1994). The rapid spread of this
isease, especially in pigs and dairy cattle, can cause major eco-
omic losses in countries that were previously FMD  free. Over 100
ountries around world are not considered FMD  free according
o the report by the World Organisation for Animal Health (OIE)
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license  (http://creativecommons.org/licenses/by/4.0/).
(World Organisation for Animal Health, 2008). FMD  is caused by a
single-stranded RNA virus belonging to the family Picornaviridae.
There are seven serotypes of the FMD  virus (FMDV), including O,
A, C, Asia 1, SAT 1, SAT 2 and SAT 3. There are a large number of
subtypes within each serotype as a result of extensive genetic and
antigenic variations (Domingo et al., 2003; Knowles and Samuel,
2003). The features that make FMD  difﬁcult to control and eradi-
cate include the wide range of hosts, ability of small doses to infect,
rapid replication, high levels of viral excretion and multiple forms
of transmission (Alexandersen et al., 2003). Frequent outbreaks and
fast spreading of FMD  indicate the need for rapid tests capable of
performing on-site diagnosis and serotyping simultaneously.
FMD  is clinically indistinguishable from other vesicular dis-
eases such as vesicular stomatitis (VS) and swine vesicular disease
(SVD) (Alexandersen et al., 2003; Jamal and Belsham, 2013). There-
fore, laboratory-based diagnoses are necessary. Various laboratory
methods are presently used for FMDV detection, including virus
isolation, real-time reverse-transcription (RRT) PCR and double
antibody sandwich (DAS) enzyme-linked immunosorbent assay
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ELISA). However, these tests are difﬁcult to perform on-site
ecause they require laboratory operations, well-trained person-
el, and special equipment/facilities. Virus isolation generally
equires up to four days before the results can be obtained, and
ntigen ELISA and RRT-PCR require four to ﬁve hours. Moreover,
pithelial or vesicular ﬂuids need to be shipped from the scene
f the suspected outbreak to the diagnostic laboratory (World
rganisation for Animal Health, 2008). Many factors, such as trans-
ortation delays, incorrect transportation media and temperatures
uring shipment, may  affect diagnostic accuracy.
A rapid and speciﬁc test for FMD  diagnosis at the site of a sus-
ected outbreak may  permit the suitable implementation of control
easures (Jamal and Belsham, 2013). Lateral ﬂow immunochro-
atographic (LFI) strip tests are widely used for the diagnosis of
nfectious diseases because these tests are quick and simple to
erform on site during a major epidemic (Kang et al., 2014). The
FI strip test was used to rapidly (<10 min) conﬁrm FMD  in the
eld during the 2007 FMD  outbreak in UK. Strip tests are efﬁ-
iently applied for the detection of speciﬁc antibodies against FMDV
on-structural proteins (Wu et al., 2011) and structural proteins of
erotypes A, Asia 1 and O (Yang et al., 2010a; Jiang et al., 2011a,b;
in et al., 2011). However, polyclonal sera from rabbits and guinea
igs were used as the capture and detection antibodies in these
ests.
Monoclonal Ab-based chromatographic strip tests for FMD  diag-
osis were developed and reported for the serotype-independent
etection of FMDV (Reid et al., 2001; Ferris et al., 2009). The strip
est was as sensitive as the conventional antigen ELISA for FMDV
etection in the epithelial suspensions tested, and it exhibited an
quivalent sensitivity for the detection of FMDV serotypes O, A, C
nd Asia 1 in cell culture supernatants. Only one speciﬁc antigen can
e detected, and the speciﬁc capture antibody is immobilized on the
embrane surface of the strip in a general LFI strip test. In this case,
he strips must be custom-made speciﬁcally for each test. SVANOVA
iotech AB has also marketed the Pan-serotypic LFI strip test. One
imiting factor for the serotype-independent strip tests is that they
annot identify the FMDV serotype, which reduces their poten-
ial beneﬁt in endemic countries. Determinations of the serotype
nvolved in outbreaks are important because there is no cross pro-
ection and speciﬁc clinical signs of each serotype, which would
llow the implementation of appropriate control/vaccination pro-
rams (Jamal and Belsham, 2013).
FMDV A, O and Asia 1 are the most widespread serotypes,
nd they are found in Africa, the Middle East, Asia, limited areas
f South America and occasionally Europe. We  previously devel-
ped a single serotype LFI strip test for FMDV (O, A, and Asia 1)
etection using serotype-speciﬁc mAbs as the capture mAb  and
 serotype-independent mAb  as the detection mAb  (Yang et al.,
013). However, a single test is speciﬁc for only one serotype. The
trip test for serotype O cannot detect the isolate, ECU4/10, which
as isolated in Ecuador in 2009 and 2010 (Maradei et al., 2011).
mada et al. (2014) developed a multiplex strip test for the serolog-
cal survey of hantavirus infections in humans, but there was  no test
vailable for multiplex FMDV detection using a single LFI strip test,
ntil now. Development of a multiplex-LFI strip test that is capa-
le of detecting several FMDV serotypes will have great potential
o diagnose and serotype FMD  in the ﬁeld to conﬁrm the clinical
ndings. The early detection and typing of FMDV infections will
rovide important information for vaccine selection and facilitate
isease control.
The current study developed a rapid multiplex-LFI strip test for
he detection of FMDV serotypes O, A and Asia 1 using commercially
vailable strips. The test lines of each strip in this study are sprayed
ith antibodies against commonly used conjugates or binding pro-
eins, such as anti-rhodamine, anti-ﬂuorescein and biotin-binding
rotein. To our knowledge, this study is the ﬁrst report to use this Methods 221 (2015) 119–126
technique in an LFI strip test. The performance of the newly devel-
oped multiplex-LFI strip tests for the detection of multiple FMDV
serotypes was  compared to other methodologies. This test can pro-
duce rapid results, and it would be useful for the early diagnosis and
serotyping of FMDV O, A and Asia 1 on-site during FMD  outbreaks.
2. Materials and methods
2.1. Ethics statement
All animal work was  performed in compliance with the
Canadian Council on Animal Care guidelines. The Animal Care Com-
mittee at the Canadian Science Centre for Animal and Human
Health approved all studies.
2.2. Preparation of FMDV and plaque assay
All viruses used in the study were provided by the FAO/OIE
World Reference Laboratory for FMD  (Pirbright Institute, Pirbright,
UK). The procedures for the preparation of FMDV were performed
as previously described (Yang et al., 2007). For plaque assay,
Mengeling–Vaughn Porcine Kidney (MVPK) cells were cultured
in Alpha Modiﬁcation of Eagle’s medium (AMEM; WISENT Inc.,
Canada) supplemented with 10% fetal bovine serum in 6-well
plates. FMDV serotypes O1/BFS, A24/Cruzeiro and Asia 1/Shamir
were serially 10-fold diluted with the culture medium. Subconﬂu-
ent MVPK monolayers in 6-well tissue culture plates were infected
with virus and overlaid with AMEM/1% SeaPlaque agarose. Overlaid
plates were incubated at 37 ◦C in a CO2 incubator overnight. Plaques
were counted after the plates were ﬁxed using 10% phosphate-
buffered formalin (Fisher Scientiﬁc) and stained using 0.05% crystal
violet.
2.3. Monoclonal antibody production, puriﬁcation and
conjugation
The procedures for mAb  production, puriﬁcation, biotinyla-
tion and colloidal-gold conjugation of mAbs were performed as
described in detail previously (Yang et al., 2007, 2013). For ﬂuo-
rescein and rhodamine conjugation, puriﬁed mAbs were buffer
exchanged against 100 mM carbonate buffer, pH 9.6, using desalt-
ing columns (GE col G-25DNA grade, Cat# 17-0853-02). Fluorescein
isothiocyanate (FITC) (MW  389.38, Sigma F4247) and rhodamine B
isothiocyanate (RITC) (MW  536.08, Sigma R1755) were dissolved
in anhydrous DMSO (1 mg/ml) immediately before use. FITC or
RITC were added to puriﬁed mAbs at a molar excess of a ratio of
approximately 20:1 and mixed immediately. The mixtures were
incubated at room temperature for 2 h. Unconjugated chemicals
were removed using a desalting column. Reagents were stored at
4 ◦C in PBS with 0.01% NaN3.
2.4. Lateral ﬂow immunochromatographic strip test for multiplex
FMDV detection
The strips that were used for this study were purchased from
RapidAssays ApS, (Copenhagen S, Denmark). Each strip contained
one control line and three test lines. The control line contained
antibodies that bound the mouse antibody that was responsible
for the immobilization of the detection conjugate at the con-
trol line. The three test lines contained biotin-binding protein,
goat-anti-rhodamine and goat anti-ﬂuorescein, which captured
antibody–antigen complexes and free conjugated capture mAbs.
Viruses in test samples (50 l) were mixed with the mAb cocktail
(50 l), which contained capture and detection mAbs in the run-
ning buffer (RapidAssays ApS, Copenhagen, Denmark) and formed
complexes. Each strip was dipped into a tube that contained the
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Fig. 1. Schematic diagram of the multiplex-LFI strip test. The control line contains antibodies that bind the colloidal gold detection mAbs. Three test lines contain goat anti-
ﬂorescein (test line 1), goat-anti-rhodamine (test line 2) and biotin-binding protein (test line 3) that capture the complex of antibodies and virus, as well as free conjugated
capture mAbs. Test samples containing viruses (50 l) were mixed with the mAb  cocktail (50 l), which contained both capture and detection mAbs in the running buffer
(RapidAssays ApS, Copenhagen, Denmark) to form a complex. The mixture migrated along the strip membrane to the test line, which bound and immobilized the serotype-
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Fpeciﬁc conjugated capture antibody. After 15 min, the results were determined u
apture  mAb, FMDV and colloid-gold conjugated detection mAb) was  demonstrate
esult  was demonstrated by a reddish-purple line at only the control line.
bove-mentioned mixture. The mixture migrated along the strip
embrane to the test line, which bound and immobilized the
erotype-speciﬁc conjugated capture antibody. The results were
etermined using visualization after 15 min. A positive result fol-
owing the accumulation of complex (conjugated-capture mAb,
MDV and colloid-gold-conjugated detection mAb) was  demon-
trated by the appearance of a reddish-purple line at one of the test
ines and the control line (Fig. 1). A negative result was demon-
trated by a reddish-purple line at the control line only.
.5. Animal experiments and tissue suspension preparation
Animal experiments, tissue and lesion swab collection and
issue suspension preparation were performed as previously
escribed (Yang et al., 2013).
. Results
.1. Monoclonal antibody selection
A total of six FMDV-speciﬁc mAbs were selected and used in the
ultiplex-LFI strip test (Table 1). All mAbs were serotype-speciﬁc,
xcept the detection mAb  F21-42, which was serotype indepen-
ent. The capture mAbs, F1O-2-5 was used for serotype O in the
reviously reported single serotype LFI strip test. However, this
Ab  failed to react with the isolate O/ECU4/10 in the DAS ELISA and
he single serotype LFI strip test, because a mutation occurred on
he mAb  (F1O-2-5) binding site of this isolate (Yang et al., 2013). The
utation was identiﬁed at amino acid position 73 of VP3. The pre-
iously produced serotype O-speciﬁc mAb  F18O-3 demonstrated
ood reactivity against O/ECU/4/10. Therefore, a mixture of mAbs
18-3 and F1O-2-5 was used as the capture mAbs. F66A22-14 and
36Asia-14 were used as capture mAbs for serotypes A and Asiaisualization. A positive result following the accumulation of complex (conjugated
 visible reddish-purple line at one of the test lines and the control line. A negative
1, respectively, which was similar to the single serotype LFI strip
tests. All capture mAbs were puriﬁed and conjugated with FITC,
RITC or biotin for serotypes O, A and Asia 1, respectively, in the
multiplex-LFI strip test.
The serotype-independent mAb  F21-42 was used as the detec-
tion mAb  in previously reported single serotype LFI strip tests (Yang
et al., 2013). However, this mAb  alone did not work well in the
multiplex-LFI strip test, because several isolates for serotypes A
and Asia 1 were not detected. DAS ELISAs were used to examine
whether this serotype-independent mAb  reacted equally with all
isolates. The results demonstrated lower binding of this mAb  to the
three serotype A isolates (A22/Iraq24/64, BKF4/94 and MAU12/06)
and the three serotype Asia 1 isolates (TUR11/12, TUR49/11, and
Shamir) than to the other isolates. The serotype A-speciﬁc mAb
F65A22-4 was examined for its reactivity against these three iso-
lates in a DAS ELISA. The results demonstrated high reactivity to
two of the three isolates. This mAb  demonstrated low reactivity to
the isolate BKF4/94, but a combination of two  detection mAbs was
more effective than the use of one mAb. The Asia 1-speciﬁc capture
mAb  F36Asia-14 was also included in the detection mAbs. These
three mAbs were puriﬁed and conjugated to 60 nm colloidal-gold
particles using Naked Gold in a BoxTM.
All mAbs in the multiplex-LFI strip test failed to recognize
the denatured viruses in an indirect ELISA, which suggests that
the epitopes recognized by these mAbs were conformational.
Tables 1 and 2 show the characterization and conjugation of the
mAbs used in the multiplex-LFI strip.
3.2. Development of multiplex immunochromatographic strip testStrips for the multiplex test contained one control line and
three test lines (Fig. 1). The control line contained an anti-mouse
antibody for the immobilization of the detection conjugate at
122 M. Yang et al. / Journal of Virological Methods 221 (2015) 119–126
Table 1
Characterization of the mAbs used in the multiplex-LFI strip test.
mAb Inoculation viral antigen Serotype speciﬁcity Isotype Binding epitope VNT result
F1O-2-5 O1/Campos O IgG1/k Conformational Negative
F18O-3 O1/BFS O IgG1/k Conformational Negative
F66A22-14 A22/Iraq A IgG2a/k Conformational Positive
F65A22-4 A22/Iraq A IgG2a/k Conformational Negative
F36Asia-14 Asia 1/Shamir Asia 1 IgG1/k Conformational Negative
F21-42 O1/BFS 7 serotypes IgG1/k Conformational Negative
Table 2
Content of the mAb  cocktail in the multiplex-LFI strip test.
mAb Conjugation Role of mAb Volume used/test
F1O-2-5 FITC Capture 0.2 l
F18O-3 FITC Capture 0.2 l
F66A22-14 RITC Capture 0.2 l
F36Asia-14 Biotin Capture 0.2 l
F65A22-4 Colloidal-gold Detection 1 l
F36Asia-14 Colloidal-gold Detection 2 l
F21-42 Colloidal-gold Detection 4 l
The mAb  cocktail contained all mAbs listed in the running buffer. 50  of the cocktail
was  used for each test.
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Table 3
The multiplex-LFI strip test results of FMDV seven serotypes, other vesicular disease
viruses and a newly emerging virus.
Virus Serotype O
Pos/totala
Serotype A
Pos/totala
Serotype Asia 1
Pos/totala
FMDV O 46/46 0/46 0/46
FMDV A 0/45 45/45 0/45
FMDV Asia 1 0/17 0/17 17/17
FMDV C 0/8 5/8 0/8
FMDV SAT 1 0/9 0/9 0/9
FMDV SAT 2 0/19 0/19 0/19
FMDV SAT 3 0/4 0/4 0/4
SVDV 0/4 0/4 0/4
VSV  (IN&NJ) 0/13 0/13 0/13
SVV  0/1 0/1 0/1
VESV 0/1 0/1 0/1
SBV  0/1 0/1 0/1
Viruses in culture supernatants (50 l) were mixed with the mAb cocktail in the
running buffer. The strips were dipped into each tube that contained the virus-mAb
mixtures. The results were recorded after 15 min. SVDV: swine vesicular disease
viruses; VSV: vesicular stomatitis viruses; IN: Indiana; NJ: New Jersey; SVV: Senecahe control line. The three test lines were sprayed with goat
nti-ﬂuorescein (test line 1), goat-anti-rhodamine (test line 2)
nd biotin-binding protein (test line 3) for serotypes O, A and
sia 1, respectively. Test samples were mixed with the mAb
ocktail that contained capture and detection mAbs (Table 2),
nd formed complexes in the running buffer. A single strip was
ipped into a tube that contained the above-mentioned mixture.
he mixture migrated along the strip membrane to the test line
nd control line. A positive result following the accumulation
f virus–antibody complexes was demonstrated by the appear-
nce of reddish-purple bands at one of the test lines (T) and the
ontrol line (C). A negative result was demonstrated by a reddish-
urple band only at the control line. The test results for serotypes
, A Asia 1 and the three mixed FMDV three serotypes demon-
trated a clear band on the test line for serotypes O, A and Asia
, respectively, with low background and no false positive results
Fig. 2).ig. 2. The multiplex-LFI strip test for FMDV serotypes O, A and Asia 1. Culture super-
atants containing FMDV were mixed with 50 l of a mAb  cocktail in the running
uffer. The strips were dipped into each tube that contained the virus-mAb mix-
ures. The results were recorded after 15 min. (a) FMDV serotype O; (b) serotype
;  (c) serotype Asia 1; (d) mixture of serotypes O, A, and Asia 1, and (e) a control
ithout virus.valley viruses; VESV: vesicular exanthema of swine virus; SBV: Schmallenberg virus.
a Tested positive numbers/tested total samples.
3.3. Speciﬁcity of the multiplex LFI strip test
Culture supernatants that contained the seven FMDV  serotypes,
other vesicular disease viruses (swine vesicular disease viruses;
vesicular stomatitis viruses; Seneca Valley viruses; and vesicular
exanthema of swine virus) and a newly emerging virus (Schmal-
lenberg virus) were examined using the multiplex-LFI strip tests
for each virus to determine speciﬁcity. All 45 serotype A ﬁeld iso-
lates that were tested demonstrated positive results using this strip
test (Table 3). The strip test failed to detect the O/ECU4/2010 isolate
for serotype O, without the addition of extra capture mAb  F18O-3,
(Fig. 3). This isolate was  detected when both capture mAbs were
included in the mAb  cocktail. These results demonstrated posi-
tive bands on the test line for all 46 serotype O ﬁeld isolates. The
multiplex-LFI strip test failed to detect 6 Asia 1 isolates (TUR/11/12,
TUR/49/11, PAK/51/11, PAK/1/12, AFG/45/11, IND/8/79) when the
Fig. 3. The multiplex-LFI strip test for FMDV/O ECU4/10 using different capture
mAbs. FMDV/O ECU4/10 (50 l) was  mixed with 50 l of a mAb cocktail that
contained different capture mAbs in the running buffer (a) FITC-F1O-2-5; (b) FITC-
F18O-3 and (c) FITC-F1O-2-5 + FITC-F18O-3. The strips were dipped into each tube
containing the virus-mAb mixtures and the results were recorded after 15 min.
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Table  4
Test results of the multiplex-LFI strip test, DAS ELISA and RRT-PCR for tissue
suspensions.
Strip test
Pos/totala
ELISA
Pos/totala
RRT-PCR
Pos/totala
Pig
(O/UKG11/2001)
4/4 4/4 4/4
Cow (O/UKG11/2001) 4/4 4/4 4/4
Pig
(A/IRN 1/09)
12/12 12/12 12/12
Pig
(Asia 1/PAK20/03)
3/3 3/3 3/3
Tissues collected from pigs experimentally inoculated with FMDV. 10% tissue sus-
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Fig. 4. Sensitivity comparisons of the multiplex-LFI strip test with DAS ELISA. Sam-ensions were prepared and tested using the multiplex-LFI strip test, DAS ELISA and
RT-PCR.
a Tested positive numbers/tested total samples.
erotype-independent mAb  was used as the detection mAb  alone.
he test detected all 17 serotype Asia 1 ﬁeld isolates after the
ddition of a serotype Asia 1-speciﬁc detection mAb  in the mAb
ocktail. Similar to the single serotype LFI strip test for serotype A,
he multiplex-LFI strip test demonstrated cross reactivity with 5 of
he 9 tested serotype C viruses (KEN 1/2004, Noville, Oberbayern,
esende and PHI7/84). All other un-related FMDV serotypes and
on-FMD vesicular disease viruses showed negative results with
o visible band on the test line. These results indicated that the
ultiplex-LFI strip tests for serotypes O and Asia 1 were speciﬁc,
ith no cross reactivity with other FMDV serotypes or vesicular dis-
ase viruses. Thirteen epithelial samples were collected from naïve
nimals (cattle, pig and sheep). Tissue suspensions (10%) were pre-
ared and tested using the LFI strip test. None of these samples
howed any visible band on the test line. It was  unreasonable to
etermine the diagnostic speciﬁcity because of the limited number
f negative samples. More negative samples must be examined to
btain a full validation.
.4. Sensitivity of the multiplex LFI strip test
FMDV serotypes O, A and Asia 1, which were ampliﬁed and
ollected from primary lamb kidney cell cultures, were two-fold
erially diluted in the running buffer (RapidAssays ApS, Copen-
agen, Denmark). The sensitivity of the strip test was  evaluated
nd compared to the DAS ELISA (Fig. 4). The band densities on the
est lines in the strip test gradually declined from strong to weak,
hich indicated that the test was dose dependent (Fig. 4). The low-
st observable viral particles per test (in 50 l) for serotype O was
7, and 3400 and 7200 for serotypes A and Asia 1, respectively. The
ultiplex-LFI strip test for different serotypes revealed different
est sensitivities. The sensitivity of the multiplex-LFI strip test was
quivalent to that of the DAS ELISA for serotypes O and A, but is less
ensitive for serotype Asia 1.
.5. Validation of the multiplex-LFI strip test with samples from
xperimentally inoculated animals
Tissue suspensions from animals inoculated with FMDV
erotypes O, A and Asia 1, were tested using the multiplex-LFI
trip test, DAS ELISA and RRT-PCR (Moniwa et al., 2007) to evalu-
te whether the multiplex-LFI strip tests detected FMDV in clinical
amples. Table 4 shows that, all tissue suspensions collected from
xperimentally inoculated cattle and pigs (tongues, foot lesion,
oronary band and heat) were identiﬁed as positive results using
he multiplex-LFI strip test, DAS ELISA and RRT-PCR.Preparation of 10% tissue suspensions on-site may  be difﬁcult
n cases of FMD  outbreaks. Therefore, swab samples were col-
ected over ruptured lesion areas using nylon ﬂocked swabs and
ested using the multiplex-LFI strip test, ELISA and RRT-PCR. Eightples containing FMDV were 2-fold serially diluted with dilution buffers. Each diluted
samples (50 l) was tested in parallel using the strip test and DAS ELISA. Viral par-
ticles were quantiﬁed using the plaque assay. (a) Serotype O; (b) Serotype A, and (c)
Serotype Asia 1.
and 14 swab samples were collected from sheep experimentally
inoculated with FMDV/O/MYA/98 and A/VIT/15/2012, respectively.
Three of the eight and seven of the 14 swab samples demon-
strated positive results for serotypes O and A, respectively, using
the multiplex-LFI strip test (Table 5). Three of the seven FMDV/A-
positive samples demonstrated weak positive results using the
strip test. Two  of these samples also showed weak positive results
(OD 0.16–0.27), and one sample revealed negative results using the
DAS ELISA. Positive detection percentages were 38% and 50% using
the multiplex-LFI strip test, 38% and 43% using the DAS ELISA and
100% and 86% using RRT-PCR for serotypes O and A, respectively.
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Table 5
Test results of the multiplex-LFI strip test, DAS ELISA and RRT-PCR for lesion swabs.
Sheep number Strip test
Pos/totala
DAS ELISA
Pos/totala
RRT-PCR
Pos/totala
#13 (O/MYA/98) 0/3 0/3 3/3
#14  (O/MYA/98) 3/3 3/3 3/3
#16  (O/MYA/98) 0/1 0/1 1/1
#19  (O/MYA/98) 0/1 0/1 1/1
Positive percentage 38% 38% 100%
#10  (A/VIT/15/2012) 0/1 0/1 0/1
#15  (A/VIT/15/2012) 2/2 2/2 2/2
#18  (A/VIT/15/2012) 0/1 0/1 1/1
#25  (A/VIT/15/2012) 1(weak)/1 1(weak)/1 1/1
#26  (A/VIT/15/2012) 0/2 0/2 1/2
#31  (A/VIT/15/2012) 2 (weak)/3 1 (weak)/3 3/3
#32  (A/VIT/15/2012) 1/1 1/1 1/1
#34  (A/VIT/15/2012) 0/1 0/1 1/1
#36  (A/VIT/15/2012) 1/2 1/2 2/2
Positive percentage 50% 43% 86%
Swabs were collected over the lesions from experimentally inoculated sheep with
FMDV (O or A) at 2 or 3 dpi and tested using the multiplex-LFI strip test, DAS ELISA,
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a Tested positive numbers/total tested samples.
. Discussion
The development of a rapid and easily performed test for FMDV
etection is important to control FMD  outbreaks and contain their
pread. LFI strip tests were developed as a method that is suitable
or rapid FMD  viral antigen and antibody detection for laboratories
nd on-site (Yang et al., 2010a,b, 2013; Jiang et al., 2007, 2011a,b;
in et al., 2009, 2011; Reid et al., 2001; Ferris et al., 2009, 2010). A
en-site strip test was also commercialized by SVANOVA Biotech
B. However, these strip tests identify one of the seven serotypes or
hey are serotype independent, which are incapable of identifying
erotypes. A multiplex-LFI strip test was developed using strips that
ontained one control line and three test lines to detect multiple
erotypes of FMDV using a single test. The test lines in the strips
re sprayed with antibodies against commonly used conjugates
r binding protein, such as anti-rhodamine, anti-ﬂuorescent and
iotin-binding protein. The advantages of using strips with multi-
le test lines are that three speciﬁc antigens can be detected using
 single strip test, and commonly used conjugates or binding pro-
eins are sprayed on the membrane. Therefore strips are ready to
se for different tests with selected speciﬁc antibodies. In addition,
ommercially available strips make assay development easier for
ormalization, standardization, and validation.
The use of mAbs is advantageous because of their high
peciﬁcity, sensitivity, and uniform afﬁnity to speciﬁc antigens.
herefore, mAbs were selected and used in the current multiplex-
FI strip test. Monoclonal Abs should be evaluated for their broad
eactivity to cover the antigenic variability of FMD  viruses because
ne mAb  recognizes a single epitope (Morioka et al., 2014). Based
n our previous report, the serotype-independent mAb  (F21-42)
hat was used in the single serotype LFI strip test was also consid-
red as the detection mAb  in the multiplex-LFI strip test. The mAb
inding epitope sequence is conserved in all FMDV seven serotypes.
he epitope of this mAb  is conformational, and the binding site is
nknown (Yang et al., 2007). However, the use of this mAb  alone
s the detection mAb  did not work well in the multiplex-LFI strip
est, because, several isolates of serotypes A and Asia 1 were not
etected. The DAS ELISA results demonstrated a lower binding of
his mAb  to some serotype A and Asia 1 isolates than of the other
solates. The explanation for this result may  be that the mixture
f several mAbs (>5) in the multiplex-LFI strip test affected their
inding sites from each other. The binding of an antibody to the
rst site may  cause steric interference with the binding of an anti-
ody to the second site. It is also possible that the binding of one Methods 221 (2015) 119–126
antibody may  cause a conformational change in the structure of the
antigen, which would inﬂuence the binding of a second antibody
to another site on the viral surface protein (Abbas et al., 2011).
Therefore, a serotype A-speciﬁc mAb  F65A22-4 was  added as
the additional detection mAb  for serotype A. Both detection mAbs
(F21-42 and F65A22-4) demonstrated low reactivity to the isolate
BKF4/94, but the two detection mAbs added together were more
effective than the use of one detection mAb. The Asia 1-speciﬁc
capture mAb F36Asia-14 was also used as a detection mAb. In gen-
eral, the capture and detection mAbs should not recognize the same
epitopes in the strip test. However, FMD  virus particles are com-
posed of 60 copies each of four structural proteins (VP1, 2, 3 and
4) (Boothroyd et al., 1982), which means that each viral particle
contains multiple identical determinants that can be bound by the
same antibody (Abbas et al., 2011). Therefore, the same mAb  can be
used for both capture and FMDV detection. All three detection mAbs
were conjugated to colloidal-gold particles using Naked Gold in a
BoxTM. This kit is easy to use for the preparation of highly reactive
gold conjugates.
As previously reported, the single serotype LFI strip test for
serotype O failed to detect one (O/ECU4/10) of the 46 isolates
because the serotype O-speciﬁc capture mAb  (F1O-2-5) was  unable
to react with this isolate (Yang et al., 2013). The sequence data
revealed that O/ECU/4/10 has many unique amino acid alterations
within the surface capsid proteins (i.e., VP1, VP2, and VP3). It is
assumed that the mutation for O/ECU/4/10 occurred at approx-
imately amino acid position 73 in the VP3 protein which is the
binding epitope of the capture mAb  F1O-2-5 (Yang et al., 2013).
Therefore, one more serotype O-speciﬁc capture mAb  that reacted
with the isolate O/ECU/4/10 was included in the mAb  cocktail. The
inclusion of this mAb  enabled the test to overcome the limitation of
a single mAb  binding to one epitope because using only one capture
mAb  may  reduce the ability to recognize viruses when antigenic
evolutions occur and result in new FMDV strains.
The capture mAbs that were selected for O and Asia 1 were
serotype-speciﬁc, but the mAb  for serotype A demonstrated cross-
reactivity with ﬁve of the nine tested serotype C isolates. It is
possible that certain serotype C isolates shared a common epitope
with serotype A for the mAb  F66A22-14. The interpretation of the
positive results for serotype A must take this common epitope into
consideration. However, no new cases of serotype C FMD  have been
reported since July 2006 (Sumption et al., 2007). Thirteen negative
epithelial samples were tested using the multiplex-LFI strip test
to determine the test sensitivity, and all of these samples demon-
strated negative results in the current study. This result suggests
100% speciﬁcity, but the number of negative samples tested was  too
small to draw any ﬁrm conclusions. The sensitivity of the multiplex-
LFI strip test was equivalent to that of the DAS ELISA for serotypes
O and A using tissue culture-derived virus. The sensitivity of the
multiplex-LFI strip test was  very high for serotype O; because it
detected as few as 20 viral particles in 50 l samples. This high
sensitivity might be because one of the capture mAb  (F18O-3) and
the serotype-independent detection mAb  (F21-42) were obtained
using O/BFS as the antigen for the inoculation of mice. Therefore, the
mAb  demonstrated high afﬁnity to the homologous virus O/BFS. The
sensitivity of multiplex-LFI strip test for serotype Asia 1 was  lower
than DAS ELISA. One possible reason might be that polyclonal anti-
bodies are used for both capture and detection in the DAS ELISA.
Polyclonal antibodies capture more viral particles through differ-
ent binding sites. The combination of more Asia 1-speciﬁc mAbs in
the multiplex-LFI strip test may  increase the sensitivity. The sensi-
tivity of the multiplex-LFI strip test was comparable to the results
reported by Lin et al. (2009).
The aim of multiplex-LFI strip test development is the
detection of FMD  viral antigens in clinical samples. Therefore, tis-
sues collected and prepared from the experimentally inoculated
ogical 
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nimals (pigs and cows) were examined. The tests correctly
evealed positive results using the multiplex-LFI strip test, DAS
LISA and RRT-PCR. However, preparation of tissue suspensions
n-site is difﬁcult. Swab samples collected over the lesion areas
rom experimentally inoculated pigs demonstrated positive results
sing the single serotype LFI strip test as reported previously (Yang
t al., 2013). Swab sample collection over lesion areas is much eas-
er than the preparation of epithelial suspensions, and it can be
asily performed in the ﬁeld. The current study examined lesion
wabs collected from experimentally inoculated sheep. Positive
irus detection for serotypes O and A are 38% and 50% using the
ultiplex-LFI strip test, 38% and 43% using the DAS ELISA and 100%
nd 86% using RRT-PCR, respectively. The test performance of the
ultiplex-LFI strip test was comparable to DAS-ELISA. It is possi-
le that viral particles that are released from the vesicle rupture
n sheep may  not be sufﬁcient to be detected by the strip test and
LISA. Similarly, Soren et al. (Alexandersen et al., 2003) indicated
hat the positive detection percentage was lower for samples from
heep, which was likely due to the difﬁculty in ﬁnding adequate
mounts of suitable epithelial lesions. LFI strip tests were unable
o consistently detect viral antigen in samples collected from nasal
wabs and sera (Ferris et al., 2009), but lesion swabs would be suit-
ble for FMDV detection, especially in pigs as previously reported
y Yang et al. (2013).
One of the advantages of the multiplex-LFI strip test is that a
ingle test can detect FMDV and serotypes simultaneously, which
equires less time to obtain results. However, the test has limi-
ations, including the inability to detect the other four serotypes
STA1, 2, 3 and C) and provide qualitative results. One positive
spect is that this study demonstrated a simple and new concept
f the use of commercially available strips to develop multiplex-
FI strip tests. The other four serotypes can also be incorporated
nto this test subsequently. Another limitation of this multiplex-LFI
trip test is that all of the mAbs used in the LFI strip test recognize
onformational epitopes. Therefore, viruses those are denatured
nder environmental conditions or during transportation will not
e detected. The sensitivity of the strip test may be slightly differ-
nt for diverse FMDV strains because FMD  viruses undergo frequent
utations that result in changes in structural proteins that affect
he mAb  binding. Another weak point of the current study is the lack
f samples collected from naturally infected animals. All samples
ested were from experimentally infected animals. More samples
ust be tested to obtain full validation of this multiplex-LFI strip
est. Similar to the ELISA, the sensitivity of the LFI strip test was
ower than that of the RRT-PCR (Longjam et al., 2011).
In conclusion, the inexpensive and rapid multiplex-LFI strip
ests that were developed in this study have great potential for
he detection of FMDV serotypes O, A, and Asia 1 to conﬁrm clinical
ndings in FMD  endemic areas and outbreak investigations, which
ould permit prevention and allow early control of epidemics.
his strip test can distinguish FMDV serotypes O, A and Asia 1 and
etect all ﬁeld isolates (O, A and Asia 1) collected at our laboratory.
he multiplex-LFI strip test exhibited similar sensitivity to that of
he ELISA, and it takes only 15 min  to acquire results. The strips
sed in this study included three test lines that were sprayed with
nti-generic conjugates that are suited for other FMDV serotypes
r viruses without modiﬁcation of the strips. However, the newly
eveloped multiplex-LFI strip test requires further validation on
iagnostic sensitivity and speciﬁcity using diverse clinical samples.
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